HomeResource LibraryCompanies AssessedDechra PharmaceuticalsDownloads

Dechra Pharmaceuticals

Follow
Key Information
HQ:
United Kingdom
Market Cap:
$4.79bn
Primary Markets:
North America, Europe
Business Type:
Pharmaceutical
Filter by:
Date
Description
Project Type
Key Topic
Content Type
May
2024
Dechra Pharmaceuticals Phase 2 Assessment
Animal Pharmaceuticals Engagement
Antibiotics & Health
Assessment
May
2023
Dechra Pharmaceuticals PLC Assessment
Animal Pharmaceuticals Engagement
Antibiotics & Health
Assessment